Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 527 participants.

Also called NCT03947619

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 527 participants (enrolled count) (from the registry)
Sponsor
  • Abiomed Inc. Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03947619
Other papers using this trial's data
  • Left Ventricular Unloading in Anterior ST-Segment Elevation Myocardial Infarction Without Shock: The ST-Segment Elevation Myocardial Infarction Door to Unload Randomized Controlled Trial Journal of the American College of Cardiology, 2026-07-07 DOI, PubMed 42029358

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada, Germany, Italy, Switzerland, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03947619. Randomized; single masking; primary purpose treatment. Start 2019-12-12 (actual); primary completion 2024-09-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
Acronym
DTU-STEMI
Condition
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
Intervention (Device)
Impella CP® placement prior to reperfusion with Primary PCI
Lead sponsor
Abiomed Inc. (class: industry)

Record details

Record id
cardio:ct-nct03947619
Content hash
154d0f908e6a87f85047c837c5be6c3331e1bb29ee4c2f1212f40482b4d4b8c4